title: Current status of liver transplantation.
abstract: Liver transplantation (LTx) is the treatment of choice for patients with end-stage liver disease (ESLD).  Improvement in outcomes (allograft and patient survival) has led to widespread use of LTx worldwide. However, new problems that include severe organ shortage, recurrence of primary disease, opportunistic infections, and development of de novo malignancies are the major problems affecting further implementation of LTx.
authors.affiliation: Department of Surgery, University of Massachusetts Medical School, Worcester, MA 01655, USA. Reza.Saidi@umassmemorial.org
authors.forename: Reza F
authors.initials: RF
authors.lastname: Saidi
mesh_terms: D005500:Follow-Up Studies; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D016031:Liver Transplantation / Q000009:adverse effects; D019520:Living Donors; D011183:Postoperative Complications / Q000209:etiology; D016896:Treatment Outcome
chemical_list: D007166:Immunosuppressive Agents